Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche span> par promoteur : Eli Lilly and Company
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A study in Patients with Episodic Cluster Headache
To assess the efficacy of LY2951742 300 mg compared to placebo in reducing the frequency of weekly cluster headache attacks.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme
Entre 18 ans
et 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
Étude I8X-MC-JECA : étude de phase 1 évaluant la sécurité de LY3200882 administré seul ou en association avec d’autres traitements chez des patients ayant des tumeurs solides.
Les tumeurs solides peuvent se développer dans n’importe quel tissu : peau, muqueuses, os, organes, etc. Ce sont les plus fréquentes puisqu’elles représentent 90 % des cancers humains. On distingue 2 ...
Pays
France
Organes
Tumeurs solides
,
Estomac
,
Pancréas
,
VADS-ORL, tout site
,
Cerveau
Spécialités
Chimiothérapie
Essai ouvert aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I disorder
The primary objective of this study is to test the superiority of olanzapine compared with divalproex in improving overall manic symptomatology in patients with mild to moderate mania associated with ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A trial comparing a drug named Abemaciclib and another drug named Docetaxel in patients with lung cancer who have already received chemotherapy treatements
Compare treatment with abemaciclib versus docetaxel therapy with respect to investigator-assessed progression-free survival (PFS) in patients with Stage IV squamous cell carcinoma NSCLC who have relap...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
The Use of Nuclear Scintigraphy to Evaluate the Anabolic Effects of Teriparatide on the Skeleton in Postmenopausal Women in Osteoporosis
To determine whether teriparatide, given as 20 mcg once daily by subcutaneous injection in postmenopausal women with osteoporosis who are at high risk for fracture, will be associated with an increase...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Phase 1b/2 Study of Gemcitabine-Cisplatin, With or Without LY2275796 Sodium, in Patients with Advanced Stage IIIB or IV Non-Small Cell Lung Cancer
The Study consists of two parts. The primary objective of Part 1 of the study is to determine a safe dose of LY2275796 in combination with gemcitabine and cisplatin for Part 2. The primary objective o...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus® in Combination with Mealtime Insulin Lispro in Adult Patients with Type 1 Diabetes Mellitus
The primary objective of this study is to test the hypothesis that LY2963016 (QD) is noninferior to Lantus (QD), as measured by change in HbA1c from baseline to 24 weeks, when used in combination with...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
Duloxetine 60 mg once daily versus Placebo in the Treatment of Patients with Osteoarthritis Knee Pain
To assess the efficacy of duloxetine 60 mg QD compared with placebo on the reduction of pain severity as measured by the Brief Pain Inventory (BPI) – Modified Short Form 24-hour average pain rating in...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
Eli Lilly and Company Limited
MAJ Il y a 5 ans
The Effect of Teriparatide Compared with Risedronate on Back Pain in Postmenopausal Women with Osteoporotic Vertebral Fractures
to compare the efficacy of teriparatide 20 µg/day versus risedronate 35 mg/week on the reduction of back pain in postmenopausal women with prevalent osteoporotic vertebral fractures associated with ch...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company Limited
MAJ Il y a 5 ans
A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed alone, and Erlotinib alone, as Second-Line Treatment for Non-Smoker Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
To compare an erlotinib-pemetrexed combination with pemetrexed alone, and erlotinib alone, in terms of progression-free survival (PFS) in non-smoker patients with locally advanced or metastatic (Stage...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Précédent
11
12
13
14
15
16
17
18
19
20
Suivant